Regulation of transcription is a complex set of events controlled by DNA sequences positioned in proximity to the genes (promoters) and by elements acting at a distance (enhancers) (1) . Promoters and enhancers that activate polymerase II transcribed mRNA genes are formed by a combinatorial puzzle of short sequences recognized by sequence-specific regulators. Some, such as the TATA, GC and CCAAT boxes, are encountered at extremely high frequency (2, 3) . The CCAAT box was one of the first elements identified (4, 5) . Later studies clearly established that such pentanucleotide sequences are present in a wide variety of vertebrate, yeast and plant promoters and are important for transcription. Performing a statistical analysis on a compilation of over 500 unrelated promoters Bucher established that the CCAAT pentanucleotide is present in ∼30% of them. They are identified by highly preferred sequences on both the 5′ and 3′ flanking sides and are most frequently located in the -60/-100 region (3). However, from this study, it was not possible to identify the protein binding and activating 'CCAAT consensus'. Over the last 15 years, with the parallel discovery of functionally important CCAAT boxes in different promoters, a plethora of CCAAT-interacting polypeptides have been detected, mainly by means of EMSA and footprinting assays. In many cases such activitities were purified and the corresponding genes cloned.
c/EBP (CCAAT/enhancer binding protein) was identified as the activator of two functionally important but apparently unrelated elements in the TK promoter and SV40 enhancer. Cloning of the genes revealed the presence of B-Zip dimerization and DNA binding domains (6, 7) . The binding sites of C/EBP are composed of palindromic repeats, occasionally containing a CCAAT pentanucleotide in the intervening sequence (8) .
CTF/NF-I (CCAAT transcription factor) also binds as a dimer to viral and cellular promoters (9) , recognizing a TGG(N) 6 GCCAA sequence (10) . A T after CCAA is sometimes present, but not strictly necessary, and binding requirements are centred on the two half palindromes, as confirmed by site selection, saturation mutagenesis and methylation interference (10, 11) .
Y Box factors, cloned by screening expression libraries with an MHC class II Y box oligo (12) , were later shown to contain a nucleic acid interacting protein domain also shared by bacterial proteins (13) . The binding specificity of such proteins is very large and includes single-stranded DNA, abasic DNA, CT-rich sequences and class III promoter elements. Moreover, they have also been involved in the control of translation (13) .
CDP (CCAAT displacement protein) was identified as a binding activity recognizing a large piece of the sea urchin histone H2B and human γ-globin promoters, both encompassing two CCAAT boxes (14, 15) . The gene contains three repeats homologous to the Drosophila CUT homeodomain (16) , each of which has a slightly different binding specificity, with the CCAAT sequence being necessary only for CR1 (16, 17) .
HSP-CBF was cloned by screening expression libraries with an HSP70 CCAAT oligo (18) .
H1TF2A has been purified by affinity chromatography with a histone H1 CCAAT box. It is a multimeric protein and one of the genes, H1TF2A, has been cloned and shown to have some similarity to the Q-rich domain of NF-YA (19, 20) . The sequence specifities of the two latter factors are not well defined.
NF-Y (also called CBF, α-CP1 and CP1) was first identified as the activity binding to the MHC class II conserved Y box (21) . Saturation mutagenensis studies performed in different laboratories clearly showed an almost absolute requirement for each of the CCAAT nucleotides (21) (22) (23) (24) . It was purified independently using *Tel: +39 2 26605239; Fax: +39 2 2664551; Email: mantor@imiucca.csi.unimi.it affinity columns containing the Y box, the α1(I) collagen CCAAT and the α-globin CCAAT (22, 23, 25) , while conventional chromatography was used to purify the yeast complex, involved in activation of cytocrome genes (26) . Recently a similar activity was purified from Neurospora crassa (27) . NF-Y is a ubiquitous heteromeric protein composed of three subunits, NF-YA, NF-YB and NF-YC, all necessary for DNA binding (28) . The mammalian and yeast genes have been cloned (25, (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . NF-Y sequences are available from several other species: the NF-YA gene was cloned from Schizosaccharomyces pombe, Brassica napus, Schistosoma mansoni and sea urchin (38) (39) (40) (41) ; NF-YB from Kluyveromyces lactis, Aspergillus nidulans, Zea mays, lamprey, Xenopus and chicken (31, 42, 43) . Each of the three subunits displayed highly conserved domains. The NF-YA homology domain can be sharply divided into subunit association and DNA contacting subdomains (34, (44) (45) (46) . NF-YB and NF-YC tight association is a prerequisite for NF-YA binding and sequence-specific DNA interactions (28) . Both NF-YB and NF-YC conserved domains contain putative histone fold motifs (47) . This motif, common to all core histones, is composed of three α-helices separated by short loop/strand regions. Enabling histones to dimerize with companion subunits, this motif is responsible for formation of the histone octamer. Recent experiments on yeast HAP3 (34), CBF-A/NF-YB (48) and CBF-C/NF-YC (49) indicate that this 65 amino acid long motif is necessary for subunit interactions and DNA binding.
NF-Y CONSENSUS DERIVED FROM NATURAL PROMOTERS
Because of the apparent multiplicity of CCAAT binding proteins, a crucial question in understanding how CCAAT sequences activate transcription is which of the activators shown to recognize this box is actually operating on a given promoter. To this end, we and others developed NF-Y reagents, such as monoclonal and polyclonal antibodies and dominant negative vectors (46, 50) , which were employed by many laboratories in EMSA supershift experiments to unambiguously identify NF-Y as the DNA-protein complex generated with CCAAT containing fragments from different promoters.
From this large body of information a database comprising all promoters shown to contain a bona fide NF-Y binding site was organized. The following criteria were used. A total of 178 bona fide NF-Y binding sites, 164 in promoters of higher eukaryotes (mainly human, rodent, chicken and Xenopus) is presented in Table 1 . Information regarding the position of the CCAAT box with respect to the +1 signal, the orientation of the CCAAT sequence, the presence in the promoter of a recognizable TATA box, the role in transcriptional activation, the proximity of binding sites for other transcription factors and the tissue distribution of the gene are also presented. In general the vast majority of these CCAAT boxes have invariably been shown to significantly contribute to overall promoter strength and, indeed, sometimes to be strictly required for activity.
Inspection of sequence alignment of all these CCAAT boxes defines the consensus for NF-Y, as can be seen from Table 2 . In general, although the number of lower eukaryote sequences is low, the NF-Y and HAP2/3/4/5 consensuses are very similar.
The CCAAT pentanucleotide
All five core nucleotides are almost invariably conserved. The rare exceptions concern position +2 (an adenine in the globin ρ enhancer and Apo-A-I and a G in the Ii promoter), position +3 (a T in CDC25 and Dpa and a G in Factor VIII) and position +5 (C in MVM P4 and yeast CYC1 and CYT1), while positions +1 and +4 are totally conserved. When measured, such as for Ii, MVM P4 and CYC1, the affinity of the variant CCAAT boxes was lower than for the intact sequence, highlighting the importance of all 5 nt.
The flanking sequences
At positions -1 and -2 there is a clear preference for purines: adenines are slightly more abundant at -2 and guanines at -1. Note that some of the high affinity NF-Y binding sites, such as α1(I) collagen and RSV, contain a C at position -2. At -3 adenines are under-represented (<10%), while C residues are more abundant (>40%). Indeed, a G→C mutation at this position in the albumin promoter increases both NF-Y binding and promoter activity. No obvious skewing is seen beyond this position. At the 3′-end guanines are well represented at positions +6/+7 and predominate at +8, but a clear preference (>50%) is given to C residues at +6 and A residues at +7. A C→A mutation at +6 and an A→C at +7 severely affects NF-Y binding to the Y box (21), while a G→C mutation at +6 of the albumin promoter increases NF-Y binding and transcriptional activity, as one would expect from the consensus. Position +10 shows several G residues and very few C residues. Finally, T residues are seldom found in close proximity to CCAAT, at positions -1/-2 and from +6 to +9. Overall, these data fit very well with methylation interference patterns (see 53). The optimal binding site encompasses 13 nt (3 nt at the 5′-end and 5 nt at the 3′-end) and thus is slightly over one turn of the double helix and it is devoid of any recognizable symmetry axis.
Further confirmation of this analysis comes from sequences that contain an intact CCAAT pentanucleotide yet bind NF-Y very inefficiently or not at all. Inspection of such sites (see Table 1 ) reinforces the importance of flanking nucleotides, both at the 5′-and 3′-ends: in β-and ε-globin, in the proximal site of gp91phox, in hamster topoisomerase IIα site V and in Fcγ receptor 1. The 5′-ends are in accordance with the consensus, except for an adenine in position -3 of the β-globin site. T residues are present at different positions between +6 and +8. The IL4 proximal, human topoisomerase IIα site V and carboxyesterase sites harbour T residues at -2 and at +7 and +6 respectively. The C residues at -2, -1 and +7 of the CD14 sites are probably responsible for its negligible affinity.
Comparison of the NF-Y consensus with the CCAAT Bucher consensus, statistically derived from random analysis of the most frequent sequences in 502 unrelated promoters, show a compelling degree of similarity. The purine preference at the 5′-end (A residues at -2 and G residues at -1), the high numbers of C residues at +6 and of A residues at +7, the equal presence of G residues at these positions, the notable absence of T residues at -2/-1/+6/+7, are all features that perfectly parallel the numbers observed for NF-Y binding CCAAT boxes (see Table 2 ). We note, however, two differences, a slight over-representation of T residues at -3 (C residues are more numerous in NF-Y binding sites) and a relative variance at +4, a position highly conserved for NF-Y. The latter discrepancy suggests that most, but not all, CCAAT sequences picked up in the Bucher study are actually NF-Y binding sites, since a minority of them, ∼15-20%, contain nucleotides that are at odds with NF-Y binding. In agreement with this, the frequency of CCAAT-containing promoters as measured by Bucher (30%) is slightly higher than that we measured on a larger sample of 1200 promoters, evaluated at 25% (M.Pontoglio and R.Mantovani, unpublished results). These subtle differences 
ARCHITECTURAL FEATURES OF NF-Y BINDING PROMOTERS
The first observation that can be made as to where the typical NF-Y binding site is positioned in regulatory regions is that it is rarely distant from the Start site: only the Ea and Dra Y′ boxes, the chicken ρ-globin 3′ enhancer and the CYP1A1, FAS and GHR CCAAT boxes are distant from proximal promoters. Indeed, the Ea/Dra and FAS genes also have NF-Y sites in their promoters. The CCAAT sequence can be found both in the direct and in the inverted orientation and it is present in both TATA-containing (such as the globins) and in TATA-less (such as MHC class II) promoters. I therefore analyzed the position of bona fide NF-Y binding sites with respect to the transcriptional +1 signal, taking into account two parameters, the orientation of the CCAAT box and the presence of a TATA box. In higher eukaryotes the CCAAT box is present in the reverse ATTGG orientation in 60% of cases, considering both the overall number of sites (99 versus 64) or the most proximal sites only (73 versus 52) (see Tables 3 and 4) .
I next verified how many of the TATA-containing and TATA-less promoters contain either a CCAAT or an ATTGG sequence and where, relative to +1, they are positioned. To derive these data I considered all promoters containing single NF-Y binding sites and the most proximal sites for those promoters in which multiple CCAAT are present. Table 4 indicates that 68 out of 119 promoters contain a TATA sequence. This figure of 57% represents a fair under-representation compared with the frequency of the TATA box in the overall promoter database as calculated in the Bucher study (79%), especially since some of the promoters Table 4 .
containing a TATA-like sequence might actually work without it. In fact, my observations are based upon the presence of a TATA consensus in the -25/-30 region, but only for very few of these regions are functional data available, indicating that the TATA sequence is indeed required. In the case of the Ea promoter, for example, a TATA-like sequence binding TBP and TFIID is present at -25, but is functionally irrelevant (54, 55) .
Comparison of the relative frequencies of CCAAT and ATTGG boxes in TATA-containing and TATA-less promoters shows clear skewing: TATA contains roughly equal numbers of CCAAT and ATTGG (40 and 43 respectively) for the total sites and 34 each if the analysis is limited to proximal sites (see Table 4 ). On the other hand, TATA-less promoters showed a significant difference in favour of ATTGG (53 versus 20 for total sites and 35 versus 16 considering proximal sites).
I then analyzed the relative distances of the CCAAT/ATTGG orientations from the Cap site, considering all NF-Y binding sites. Table 5 shows a peak of ATTGG in the -61/-80 area and many sites located between -41 and -60, while CCAAT is evenly distributed in more upstream regions, from -61 to -100. Note the relatively high number of ATTGG upstream sites beyond -120. This is largely due to a limited number of promoters with sequences from multiple species, such as topoisomerase IIα, containing several NF-Y sites. By limiting the analysis to proximal sites, the actual number of promoters in which each NF-Y/TATA arrangement is present can be more precisely calculated (Table 5 ): in the CCAAT-TATA combination the NF-Y sites have a peak between -80 and -100 (mean value 93 ± 25) and 74% of the sites are between -60 and -100; in most of the ATTGG-TATA-less promoters (62%) the NF-Y binding sites are located between -41 and -80 (mean value 63 ± 29). A similar situation is observed with CCAAT-TATA-less, whereas in ATTGG-TATA most of the NF-Y binding sites are in the -80/-100 region. Moreover, it is important to note that in the presence of a TATA box the NF-Y binding CCAAT box is never closer than -48 in the reverse ATTGG configuration or -62 in the The list of NF-Y binding sites is as of September 1997. GENE, the name of the gene is indicated as well as the CCAAT sequence in the promoter. P and D indicate proximal and distal sites respectively. ORG, abbreviated names of the different species: Hs, man; Rn, rat; Mm, mouse; Bt, bovine; Sp, rabbit; Gg, chicken; Xl, Xenopus laevis; Xt, Xenopus tropicalis; Gc, galago; Ha, hamster; Cc, quail; Aa, goose; Sm, Schistosoma mansoni; Sc, Saccharomyces cerevisiae; An, Aspergillus nidulans; Nc, Neurospora crassa. OR indicates the orientation of the NF-Y site: > is forward CCAAT; < is reverse ATTGG. POS is the CCAAT position with respect to the +1 signal, calculated taking into account the central +3 A. TATA indicates whether the promoter has a consensus TATA sequence in the -20/-30 region. ACT refers to a positive effect on promoter activity, as tested in functional assays either in vitro or in vivo. TF indicates the presence of a proven binding site for a transcription factor close to the NF-Y binding site. COMP indicates whether cross-competition data with bona fide NF-Y binding sites are available. AB indicates whether EMSA supershift experiments with anti-NF-Y antibodies were performed. EXPR refers to the tissue or cell type specificity of the gene activated by NF-Y: Bl, B lymphocytes; Tl, T lymphocytes; Mo, macrophages; Gr, granulocytes; Ery, erythroid cells; Bo, bone; Sk, skeletal muscle; Li, liver; Sp, spleen; Lu, lung; Ad, adipocytes; My, myoblasts; He, heart; Fi, fibroblast; Sm, smooth muscle; Ec, embryonal carcinoma; Br, brain; U, ubiquitous; Uind, ubiquitous and inducible; Ts, testis. REF is the reference number. HAP/2/3/4/5 indicates the dependence of the promoter from intact HAP genes. forward CCAAT. It is usually positioned at ∼60 nt from the TBP binding site, irrespective of orientation. In the absence of a recognizable TATA box, however, NF-Y sites are much closer to +1 and in some cases indeed overlap the transcriptional site. Among the several such examples we find the cell cycle-regulated genes cdc2, CDC25, cyclin A and cyclin B1, which seem to prefer the multiple CCAAT-TATA-less configuration.
In conclusion, NF-Y sites show a predominance in proximal promoter regions; the CCAAT/ATTGG position is far from being randomly distributed, both in terms of orientation and presence of a neighbouring TATA box. We take these data as yet another indication that NF-Y can serve multiple architectural roles in the functional organization of different classes of promoters and it is possible that, in the absence of TBP-TATA interactions in the -25 region, NF-Y functions as the pivotal factor in connecting upstream activators with the general transcription machinery, thus helping polymerase II to focus on the Start site(s).
